Vertebrate heart growth is regulated by functional antagonism between Gridlock and Gata5

Department of Medicine and Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 09/2007; 104(35):14008-13. DOI: 10.1073/pnas.0702240104
Source: PubMed


Embryonic organs attain their final dimensions through the generation of proper cell number and size, but the control mechanisms remain obscure. Here, we establish Gridlock (Grl), a Hairy-related basic helix-loop-helix (bHLH) transcription factor, as a negative regulator of cardiomyocyte proliferative growth in zebrafish embryos. Mutations in grl cause an increase in expression of a group of immediate-early growth genes, myocardial genes, and development of hyperplastic hearts. Conversely, cardiomyocytes with augmented Grl activity have diminished cell volume and fail to divide, resulting in a marked reduction in heart size. Both bHLH domain and carboxyl region are required for Grl negative control of myocardial proliferative growth. These Grl-induced cardiac effects are counterbalanced by the transcriptional activator Gata5 but not Gata4, which promotes cardiomyocyte expansion in the embryo. Biochemical analyses show that Grl forms a complex with Gata5 through the carboxyl region and can repress Gata5-mediated transcription via the bHLH domain. Hence, our studies suggest that Grl regulates embryonic heart growth via opposing Gata5, at least in part through their protein interactions in modulating gene expression.

  • Source
    • "Whole mount in situ hybridizations were carried out as described (Zhong et al., 2001) using antisense ribonucleotide probes for nkx2.5, cmlc2, vmhc, scl, myoD and insulin. Immunofluorescence was performed as described (Jia et al., 2007) using primary anti-phosphorylated histone H3 antibody (1:100; Santa Cruz Biotechnology) and secondary antibody Alexa Fluor 555 donkey anti-rabbit conjugate (1:200; Molecular Probes). "
    [Show abstract] [Hide abstract]
    ABSTRACT: We have developed a robust in vivo small-molecule screen that modulates heart size and cardiomyocyte generation in zebrafish. Three structurally related compounds (Cardionogen-1 to Cardionogen-3) identified from our screen enlarge the size of the developing heart via myocardial hyperplasia. Increased cardiomyocyte number in Cardionogen-treated embryos is due to expansion of cardiac progenitor cells. In zebrafish embryos and murine embryonic stem (ES) cells, Cardionogen treatment promotes cardiogenesis during and after gastrulation, whereas it inhibits heart formation before gastrulation. Cardionogen-induced effects can be antagonized by increasing Wnt/β-catenin signaling activity. We demonstrate that Cardionogen inhibits Wnt/β-catenin-dependent transcription in murine ES cells and zebrafish embryos. Cardionogen can rescue Wnt8-induced cardiomyocyte deficiency and heart-specific phenotypes during development. These findings demonstrate that in vivo small-molecule screens targeting heart size can reveal compounds with cardiomyogenic effects and identify underlying target pathways.
    Full-text · Article · Dec 2011 · Chemistry & biology
  • Source
    • "To determine endogenous hey2/grl expression, we performed WISH study of grl expression during embryonic zebrafish development (Figure S1). Grl expression is observed only at the LPM as shown previously [10], and at the midline (Figure S1). Notch1 and Notch4 are the endothelial specific Notch [11]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vasculogenesis, the de novo formation of blood vessels from precursor cells is critical for a developing embryo. However, the signals and events that dictate the formation of primary axial vessels remain poorly understood. In this study, we use ets-related protein-1 (etsrp), which is essential for vascular development, to analyze the early stages of vasculogenesis in zebrafish. We found etsrp(+) cells of the head, trunk and tail follow distinct developmental sequences. Using a combination of genetic, molecular and chemical approaches, we demonstrate that fli(+)etsrp(+) hemato-vascular progenitors (FEVPs) are proliferating at the lateral plate mesoderm (LPM). The Shh-VEGF-Notch-Hey2 signaling pathway controls the proliferation process, and experimental modulation of single components of this pathway alters etsrp(+) cell numbers at the LPM. This study for the first time defines factors controlling proliferation, and cell numbers of pre-migratory FEVPs in zebrafish.
    Full-text · Article · Feb 2011 · PLoS ONE
  • Source
    • "transcriptional activity leading to inhibition of myocardial proliferation (Jia et al., 2007). By contrast, the hearts of the zebrafish mutants heart of glass (heg), santa (san) and valentine (val) do not show concentric growth because they fail to add additional myocardial cell layers, even though the total cell number is not altered. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular disease (CVD) has recently overtaken infectious disease to become the biggest global killer. Genetic factors have emerged as being of major importance in the pathogenesis of CVD. Owing to disease heterogeneity, variable penetrance and high mortality, human genetic studies alone are not sufficient to elucidate the genetic basis of CVD. Animal models are needed to identify novel genes that are involved in cardiovascular pathology and to verify the effect of suspected disease genes on cardiovascular function. An intriguing model organism is the zebrafish danio rerio. Several features of the zebrafish, such as a closed cardiovascular system, transparency at embryonal stages, rapid and external development, and easily tractable genetics make it ideal for cardiovascular research. Moreover, zebrafish are suitable for forward genetics approaches, which allow the unbiased identification of novel and unanticipated cardiovascular genes. Zebrafish mutants with various cardiovascular phenotypes that closely correlate with human disease, such as congenital heart disease, cardiomyopathies and arrhythmias, have been isolated. The pool of zebrafish mutants, for which the causal gene mutation has been identified, is constantly growing. The human orthologues of several of these zebrafish genes have been shown to be involved in the pathogenesis of human CVD. Cardiovascular zebrafish models also provide the opportunity to develop and test novel therapeutic strategies, using innovative technologies such as high throughput in vivo small molecule screens.
    Full-text · Article · Feb 2009 · Disease Models and Mechanisms
Show more